Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Future Growth Projections For The Antiemetics And Antinauseants Market Size?

The market size of antiemetics and antinauseants has been consistently escalating in the past few years. There is an expectation of growth from $8.19 billion in 2024 to $8.48 billion in 2025, experiencing a compound annual growth rate (CAGR) of 3.6%. The past growth is due to factors like historical branding, market competition, preferences in past treatments, economic circumstances, past global health instances, and improvements in medicine and research.

The market for antiemetics and antinauseants is projected to experience consistent growth in the upcoming years, escalating to “$9.64 billion by the year 2029 at a Compound Annual Growth Rate (CAGR) of 3.3%. Factors influencing this prediction of growth for the forecasted period include extensive research and development efforts, economic conditions, competitive market environment, industry dynamics, shifts in disease prevalence, and alterations in healthcare policies and regulations. The forecast period is set to witness notable trends such as enhanced emphasis on patient experiences, modifications in healthcare policies, a consumer preference shift towards non-invasive treatments, an increase in instances of chemotherapy and pregnancy-induced nausea and the advent of targeted therapies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

What Are The Primary Factors Supporting The Antiemetics And Antinauseants Market Expansion?

The market for antiemetics and antinauseants is driven upward by a rising rate of cancer prevalence. Nausea and vomiting, related to the chemotherapy often used to treat cancer, are unfortunate side effects of this treatment. However, 60% to 70% of patients can prevent these effects with the use of antiemetic drugs. For example, The American Cancer Society, a U.S-based nonprofit, projected in April 2024 that there were approximately 609,000 deaths due to cancer and an expected 1.9 million new diagnoses of cancer in the U.S. in 2022. A slight increase in mortality rates to an estimated 620,000 deaths is anticipated in 2024. As cancer incidents rise, so will demand for antiemetics and antinauseants, propelling revenue within the market.

How Is The Antiemetics And Antinauseants Market Categorized Across Applications And Types?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

How Are Market Trends Influencing Competition In The Antiemetics And Antinauseants Market?

Leading businesses in the antiemetic and antinauseant industry are focusing on the development of new product innovations like ready-to-use injectables in an effort to enhance treatment procedures and improving patient adherence. These newly developed formulations aim to offer immediate efficacy, simplifying the procedure and reducing the time involved with traditional injectable medications. A notable example is in July 2024, the US-based specialty pharmaceutical firm, Amneal Pharmaceuticals, introduced FOCINVEZ—an injectable format of fosaprepitant, which is designed to combat acute and delayed nausea and vomiting, typically linked to cancer chemotherapy that is highly emetogenic. The product can be found in a 150 mg/50 mL vial, does not contain Polysorbate 80, and eliminates the need for reconstitution or dilution, making it suitable for immediate use. FOCINVEZ is authorized for adults and children aged six months and above, with a distinctive J-Code (J1434) for reimbursement purposes.

Who Are The Global Leaders Steering The Antiemetics And Antinauseants Market Forward?

Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

What Are The Emerging Regional Trends Driving The Antiemetics And Antinauseants Market?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model